Kirin Holdings management has avoided addressing significant questions on logic and viability of KV2027 “bridging” strategy LONDON--(BUSINESS WIRE)--Independent Franchise Partners, LLP (“Franchise ...

(RTTNews) - Adial Pharmaceuticals, Inc. (ADIL), a clinical-stage biopharmaceutical company, announced on Tuesday that it has received positive feedback from the U.S. Food and Drug Administration or ...

On Tuesday, Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) announced a positive response from the U.S. Food and Drug Administration (FDA) regarding its proposed in vitro bridging strategy for AD04. The FDA ...

There are many hot conversations in biopharma today: market access, AI, transforming field operations. ClinicalMind’s Tom Sproat and 11Ten’s James Lewis discuss how leaders in biopharma can move these ...

AUSTIN, TX - March 16, 2026 (NEWMEDIAWIRE) - In the intricate landscape of modern business, a notable disconnect often arises between the strategies set forth by executives and the actual execution of ...

As part of IFC India 2025, our workstream on Fossil Fuel Adaptation and Renewable Energy studied one of India’s most ...

The Bank says brokers are increasingly structuring short-term funding as part of a wider, multi-stage investment strategy.